)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
TScan Therapeutics
TScan Therapeutics (TCRX) investor relations material
TScan Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary20 May, 2026
Opening remarks and agenda
Meeting called to order by the CEO, acting as Chairman, with formal business limited to official agenda items.
Directors, executive team, and representatives from Deloitte & Touche LLP and Goodwin Procter LLP recognized.
Stockholders of record as of April 15, 2026, were eligible to vote, with meeting rules and procedures outlined.
Board and executive committee updates
Two nominees, Katina Dorton and R. Keith Woods, were nominated for Class 2 director positions for a three-year term.
No stockholder nominations for directors were received in advance.
Corporate governance
Deloitte & Touche LLP was proposed for ratification as independent registered public accounting firm for fiscal year ending December 31, 2026.
Ratification of the auditor was presented as a matter of good corporate governance, though not required by bylaws.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from TScan Therapeutics
- Q1 2026 net loss narrowed to $28.7M, strong cash runway, and pivotal TCR-T trials set for 2026.TCRX
Q1 20266 May 2026 - Stockholders will vote on director elections, auditor ratification, and doubling authorized shares.TCRXProxy filing17 Apr 2026
- TCR T cell therapy shows >50% relapse reduction in AML/MDS, pivotal trial starts mid-2024.TCRX25th Annual Needham Virtual Healthcare Conference15 Apr 2026
- Key votes include director elections, auditor ratification, and doubling authorized voting shares.TCRXProxy filing7 Apr 2026
- TCR-T pipeline advances with pivotal trial, broad market reach, and strong clinical data.TCRXCorporate presentation5 Mar 2026
- Pivotal trial for relapse-preventing T-cell therapy launches in Q2, targeting major market expansion.TCRXTD Cowen 46th Annual Health Care Conference4 Mar 2026
- Strong clinical and financial progress, with cash runway into H2 2027.TCRXQ4 20254 Mar 2026
- Sequential IL-17/IL-23 therapy targets rapid, durable psoriasis control with strong funding and pivotal data ahead.TCRXBofA Securities 2025 Healthcare Conference3 Feb 2026
- Strong efficacy in AML/MDS and multiplex solid tumor strategy set stage for pivotal trials.TCRXMorgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026
Next TScan Therapeutics earnings date
Q2 202611 Aug, 2026
TScan Therapeutics
Next TScan Therapeutics earnings date
Q2 202611 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage